144 related articles for article (PubMed ID: 25414430)
1. Health-related quality of life after successful surgery for primary hyperparathyroidism: no additive effect from vitamin D supplementation: results of a double-blind randomized study.
Åberg V; Norenstedt S; Zedenius J; Sääf M; Nordenström J; Pernow Y; Nilsson IL
Eur J Endocrinol; 2015 Feb; 172(2):181-7. PubMed ID: 25414430
[TBL] [Abstract][Full Text] [Related]
2. Primary hyperparathyroidism and metabolic risk factors, impact of parathyroidectomy and vitamin D supplementation, and results of a randomized double-blind study.
Norenstedt S; Pernow Y; Brismar K; Sääf M; Ekip A; Granath F; Zedenius J; Nilsson IL
Eur J Endocrinol; 2013 Dec; 169(6):795-804. PubMed ID: 24026893
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D supplementation after parathyroidectomy: effect on bone mineral density-a randomized double-blind study.
Norenstedt S; Pernow Y; Zedenius J; Nordenström J; Sääf M; Granath F; Nilsson IL
J Bone Miner Res; 2014 Apr; 29(4):960-7. PubMed ID: 24115138
[TBL] [Abstract][Full Text] [Related]
4. No beneficial effects of vitamin D supplementation on muscle function or quality of life in primary hyperparathyroidism: results from a randomized controlled trial.
Rolighed L; Rejnmark L; Sikjaer T; Heickendorff L; Vestergaard P; Mosekilde L; Christiansen P
Eur J Endocrinol; 2015 May; 172(5):609-17. PubMed ID: 25646406
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism.
Moosgaard B; Vestergaard P; Heickendorff L; Melsen F; Christiansen P; Mosekilde L
Clin Endocrinol (Oxf); 2005 Nov; 63(5):506-13. PubMed ID: 16268801
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D treatment in primary hyperparathyroidism: a randomized placebo controlled trial.
Rolighed L; Rejnmark L; Sikjaer T; Heickendorff L; Vestergaard P; Mosekilde L; Christiansen P
J Clin Endocrinol Metab; 2014 Mar; 99(3):1072-80. PubMed ID: 24423366
[TBL] [Abstract][Full Text] [Related]
7. Persistent elevation in serum parathyroid hormone levels in normocalcemic patients after parathyroidectomy: does it matter?
Carsello CB; Yen TW; Wang TS
Surgery; 2012 Oct; 152(4):575-81; discussion 581-3. PubMed ID: 23021134
[TBL] [Abstract][Full Text] [Related]
8. Primary hyperparathyroidism: findings from the retrospective evaluation of cases over a 6-year period from a regional UK centre.
Pappachan JM; Elnaggar MN; Sodi R; Jbeili K; Smith PR; Lahart IM
Endocrine; 2018 Oct; 62(1):174-181. PubMed ID: 30019307
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D therapy in patients with primary hyperparathyroidism and hypovitaminosis D.
Tucci JR
Eur J Endocrinol; 2009 Jul; 161(1):189-93. PubMed ID: 19383807
[TBL] [Abstract][Full Text] [Related]
10. Parathyroidectomy, elevated depression scores, and suicidal ideation in patients with primary hyperparathyroidism: results of a prospective multicenter study.
Weber T; Eberle J; Messelhäuser U; Schiffmann L; Nies C; Schabram J; Zielke A; Holzer K; Rottler E; Henne-Bruns D; Keller M; von Wietersheim J
JAMA Surg; 2013 Feb; 148(2):109-15. PubMed ID: 23560281
[TBL] [Abstract][Full Text] [Related]
11. Oral vitamin D supplementation reduces the incidence of eucalcemic PTH elevation after surgery for primary hyperparathyroidism.
Beyer TD; Solorzano CC; Prinz RA; Babu A; Nilubol N; Patel S
Surgery; 2007 Jun; 141(6):777-83. PubMed ID: 17560254
[TBL] [Abstract][Full Text] [Related]
12. Effect of vitamin D supplementation on cardiometabolic risks and health-related quality of life among urban premenopausal women in a tropical country--a randomized controlled trial.
Ramly M; Ming MF; Chinna K; Suboh S; Pendek R
PLoS One; 2014; 9(10):e110476. PubMed ID: 25350669
[TBL] [Abstract][Full Text] [Related]
13. Mild primary hyperparathyroidism: vitamin D deficiency and cardiovascular risk markers.
Farahnak P; Lärfars G; Sten-Linder M; Nilsson IL
J Clin Endocrinol Metab; 2011 Jul; 96(7):2112-8. PubMed ID: 21593116
[TBL] [Abstract][Full Text] [Related]
14. Further insights into the pathogenesis of primary hyperparathyroidism: a nested case-control study.
Rejnmark L; Amstrup AK; Mollerup CL; Heickendorff L; Mosekilde L
J Clin Endocrinol Metab; 2013 Jan; 98(1):87-96. PubMed ID: 23150677
[TBL] [Abstract][Full Text] [Related]
15. Bone mineral density evolution after successful parathyroidectomy in patients with normocalcemic primary hyperparathyroidism.
Koumakis E; Souberbielle JC; Sarfati E; Meunier M; Maury E; Gallimard E; Borderie D; Kahan A; Cormier C
J Clin Endocrinol Metab; 2013 Aug; 98(8):3213-20. PubMed ID: 23783096
[TBL] [Abstract][Full Text] [Related]
16. Determinants of urolithiasis before and after parathyroidectomy in patients with primary hyperparathyroidism.
Elkoushy MA; Yu AX; Tabah R; Payne RJ; Dragomir A; Andonian S
Urology; 2014 Jul; 84(1):22-6. PubMed ID: 24703459
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D and primary hyperparathyroidism (PHPT).
Souberbielle JC; Maury E; Friedlander G; Cormier C
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):199-203. PubMed ID: 20398761
[TBL] [Abstract][Full Text] [Related]
18. Over-supplementation of vitamin D in two patients with primary hyperparathyroidism.
Battista C; Viti R; Minisola S; Chiodini I; Frusciante V; Scillitani A; Carnevale V
Hormones (Athens); 2013; 12(4):598-601. PubMed ID: 24457409
[TBL] [Abstract][Full Text] [Related]
19. The effect of parathyroidectomy on quality of life in primary hyperparathyroidism: evaluation with using sf-36 and phpqol questionnaire.
Somuncu E; Kara Y
Endocr J; 2021 Jan; 68(1):87-93. PubMed ID: 32879163
[TBL] [Abstract][Full Text] [Related]
20. Effect of Parathyroidectomy Upon Left Ventricular Mass in Primary Hyperparathyroidism: A Meta-Analysis.
McMahon DJ; Carrelli A; Palmeri N; Zhang C; DiTullio M; Silverberg SJ; Walker MD
J Clin Endocrinol Metab; 2015 Dec; 100(12):4399-407. PubMed ID: 26445115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
